Catalyst Wire Dossier Catalyst Wire Dossier

RP1

· Replimune, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for RP1, covering 2025-01-27 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies [Phase 1, Phase 2]

See pricing